| Financial Year |
March 31 2023 |
| Monetary Funds |
1,378,886,187.30 |
| Held-for-trading Financial Assets |
1,144,927,367.74 |
| Notes Receivable |
658,563,337.64 |
| Accounts Receivable |
931,443,476.25 |
| Advances to Suppliers |
84,012,577.56 |
| Other Receivables |
2,808,255.08 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,149,678,867.25 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,457,237.68 |
| Total Current Assets |
5,447,562,092.77 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
2,352,840,528.99 |
| Under-construction Projects |
497,237,540.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
258,687,477.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
31,881,194.13 |
| Other Non-Current Assets |
342,072,856.75 |
| Sub-Total of Non-Current Assets |
3,482,769,597.68 |
| Total Assets |
8,930,331,690.45 |
| Short-Term Loans |
6,760,731.99 |
| Trading Financial liabilities |
-- |
| Notes Payable |
730,914,799.85 |
| Accounts Payable |
637,637,640.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
15,165,599.35 |
| Taxes Payable |
43,545,860.36 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
108,758,771.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
144,627,768.67 |
| Sub-Total of Current Liabilities |
1,745,029,252.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
57,224,373.19 |
| Total Liabilities |
1,802,253,625.27 |
| Paid-In Capital(Or Share Stock) |
663,614,113.00 |
| Capital Surplus |
2,687,120,521.29 |
| Surplus Reserve |
469,422,189.93 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,232,561,516.11 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,128,078,065.18 |
| Owner's Equity（Stockholder's Equity） |
7,128,078,065.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,930,331,690.45 |
